Adcetris

ASH: Seattle Genetics rolls into latest Adcetris launch with double survival win
Fierce Biotech
Tue, 12/4/18 - 09:41 am
Seattle Genetics
Adcetris
ASH 2018
T-cell lymphoma
Adcetris gets speedy label expansion under FDA real-time pilot
BioCentury
Sat, 11/17/18 - 12:37 pm
FDA
Adcetris
Seattle Genetics
label expansions
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
CP Wire
Mon, 11/5/18 - 11:19 am
Seattle Genetics
Adcetris
T-cell lymphoma
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
Mon, 11/5/18 - 10:08 am
Seattle Genetics
Adcetris
T-cell lymphoma
Seattle Genetics sags as Adcetris sales miss target
BioCentury
Fri, 10/26/18 - 08:34 pm
Seattle Genetics
earnings
Adcetris
Seattle Genetics' Adcetris Has Potential to Change Treatment for T-Cell Lymphoma
BioSpace
Mon, 10/8/18 - 11:36 pm
Seattle Genetics
Takeda
Adcetris
peripheral T-cell lymphoma
Seattle Genetics' and Takeda's Adcetris Meets Primary and Secondary Endpoints in Ph III Trial for T-Cell Lymphoma
CP Wire
Mon, 10/1/18 - 09:40 am
Seattle Genetics
Takeda
Adcetris
T-cell lymphoma
Seattle Genetics' and Takeda's Adcetris Meets Primary and Secondary Endpoints in Ph III Trial for T-Cell Lymphoma
Mon, 10/1/18 - 09:33 am
Seattle Genetics
Takeda
Adcetris
T-cell lymphoma
Why Seattle Genetics Jumped Higher Today
Motley Fool
Fri, 04/27/18 - 08:06 pm
Seattle Genetics
earnings
Adcetris
Seattle Genetics Gains Another FDA Approval
BioSpace
Thu, 03/22/18 - 09:00 am
Seattle Genetics
FDA
Adcetris
Hodgkin's lymphoma
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
Fri, 01/5/18 - 05:33 pm
cancer
Merck
Japan
Keytruda
Seattle Genetics
Adcetris
Novartis
Kisqali
ASH: Seattle Genetics CEO sees a big new Adcetris market, but one analyst has some doubts
Fierce Pharma
Mon, 12/11/17 - 11:35 am
ASH17
Seattle Genetics
Adcetris
Hodgkin's lymphoma
ASH17: Seattle Genetics sees market opportunity in cancer combo success
BioPharma Dive
Sun, 12/10/17 - 09:59 am
ASH17
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion
Yahoo/Zacks.com
Mon, 11/13/17 - 10:39 am
Seattle Genetics
Adcetris
FDA
primary cutaneous anaplastic large cell lymphoma
Inching closer to blockbuster status, Seattle Genetics gets fourth FDA win for Adcetris
Endpoints
Fri, 11/10/17 - 11:26 am
Seattle Genetics
FDA
Adcetris
cutaneous T-cell lymphoma
Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma
Forbes
Mon, 06/26/17 - 10:23 am
Seattle Genetics
Takeda
Hodgkin's lymphoma
Adcetris
Bristol-Myers and Seattle Genetics move a promising flagship combo into PhIII
Endpoints
Fri, 06/2/17 - 11:16 am
Bristol-Myers
Seattle Genetics
Opdivo
Adcetris
Hodgkin's lymphoma
Immunomedics, Seattle Genetics Lead Biotech Movers on Deal News
TheStreet.com
Fri, 02/10/17 - 09:52 am
Immunomedics
Seattle Genetics
M&A
solid tumors
Adcetris
Standing Up To The Test Of Time: Two Cancer Drugs That Could Survive A Hobbled FDA
Forbes
Thu, 12/8/16 - 09:59 am
FDA
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
AbbVie
JNJ
Ibruvica
mantle cell lymphoma
Seattle Genetics moves up FDA timeline for cash cow drug Adcetris
Bizjournals.com
Sat, 11/12/16 - 09:13 am
Seattle Genetics
FDA
Adcetris
lymphoma

Pages